PB 117 of 2021
National Health (Chemotherapy Prescribing) Consequential Amendments Special Arrangement 2021
I, Adriana Platona, delegate of the Minister for Health and Aged Care, make the following instrument.
Dated 27 October 2021
Adriana Platona
First Assistant Secretary
Technology Assessment and Access Division
Department of Health
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1 — Amendments
National Health (Chemotherapy Prescribing) Special Arrangement 2020 (PB 52 of 2020)
(1) This instrument is the National Health (Chemotherapy Prescribing) Consequential Amendments Special Arrangement 2021.
(2) This instrument may also be cited as PB 117 of 2021.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 November 2021. | 1 November 2021. |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under section 100 of the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
National Health (Chemotherapy Prescribing) Special Arrangement 2020 (PB 52 of 2020)
1 Subsection 5(1) (definition of authorised prescriber)
Repeal the definition, substitute:
authorised prescriber, for a pharmaceutical benefit, means a PBS prescriber (within the meaning of Part VII of the Act) authorised under section 9 or 9A of the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 to write a prescription for the supply of the benefit.